VRP.L Regulatory News (VRP)

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr. Jan-Anders Karlsson

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Verona Pharma plc

b)

LEI

n/a

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5 pence each

GB00BYW2KH80

b)

Nature of the transaction

Jan-Anders Karlsson purchased 19,750 Ordinary Shares

c)

Price(s) and volume(s)

d)

Aggregated information

- Aggregated volume

- Price

19,750 Ordinary Shares at 149 pence per Ordinary Share

e)

Date of the transaction

12,000 Ordinary Shares on 28 February 2017 and 7,750 Ordinary Shares on 1 March 2017

f)

Place of the transaction

London Stock Exchange, AIM